Asset Dedication LLC’s BioMarin Pharmaceuticals BMRN Stock Holding History

Asset Dedication LLC’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-240	Closed	-$19.8K	–	1171
2024 Q2	$19.8K	Buy	+240	New	+$20K	﹤0.01%	682
2023 Q3	–	Sell	-54	Closed	-$5K	–	994
2023 Q2	$5K	Hold	54	–	–	﹤0.01%	767
2023 Q1	$5K	Hold	54	–	–	﹤0.01%	741
2022 Q4	$6K	Hold	54	–	–	﹤0.01%	714
2022 Q3	$5K	Hold	54	–	–	﹤0.01%	705
2022 Q2	$4K	Hold	54	–	–	﹤0.01%	411
2022 Q1	$4K	Hold	54	–	–	﹤0.01%	769
2021 Q4	$5K	Hold	54	–	–	﹤0.01%	730
2021 Q3	$4K	Hold	54	–	–	﹤0.01%	809
2021 Q2	$5K	Hold	54	–	–	﹤0.01%	701
2021 Q1	$4K	Hold	54	–	–	﹤0.01%	566
2020 Q4	$5K	Hold	54	–	–	﹤0.01%	626
2020 Q3	$4K	Hold	54	–	–	﹤0.01%	613
2020 Q2	$7K	Hold	54	–	–	﹤0.01%	492
2020 Q1	$5K	Hold	54	–	–	﹤0.01%	510
2019 Q4	$5K	Hold	54	–	–	﹤0.01%	535
2019 Q3	$4K	Hold	54	–	–	﹤0.01%	517
2019 Q2	$5K	Hold	54	–	–	﹤0.01%	489
2019 Q1	$5K	Hold	54	–	–	﹤0.01%	517
2018 Q4	$5K	Hold	54	–	–	﹤0.01%	481
2018 Q3	$5K	Sell	54 -1	-2%	-$100	﹤0.01%	516
2018 Q2	$5K	Buy	55 +1	+2%	+$88	﹤0.01%	530
2018 Q1	$4K	Buy	+54	New	+$4.63K	﹤0.01%	448
2016 Q1	–	Sell	-128	Closed	-$13K	–	438
2015 Q4	$13K	Buy	+128	New	+$13.4K	0.01%	360

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Asset Dedication LLC's BMRN Position: Q3 2024 in Review

Asset Dedication LLC sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2024, closing a stake of 240 shares — an estimated $19.8K sold.

Asset Dedication LLC first reported a position in BMRN in Q4 2015 and held it in 24 quarters. The position peaked at $19.8K in Q2 2024. 553 funds tracked by Wall St. Rank hold BMRN as of Q3 2024.

Asset Dedication LLC reported no remaining BioMarin Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
Asset Dedication LLC sold 240 BioMarin Pharmaceuticals shares in Q3 2024, an estimated $19.8K.
Asset Dedication LLC first reported a position in BioMarin Pharmaceuticals in Q4 2015 and held it in 24 quarters.
Asset Dedication LLC's BioMarin Pharmaceuticals position peaked at $19.8K in Q2 2024.
553 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2024.

Based on Asset Dedication LLC's 13F filing for Q3 2024, filed 15 Oct 2024.